INSTRUCTIONS FOR AUTHORS

Manuscript submission

Editorial System is an online submission and review system. Authors must submit their manuscripts and track their progress through the system. In order to access the Editorial System, please submit your manuscript at https://www.editorialsystem.com/appd

 

IMPORTANT INFORMATION

Since January 2017 there is a publication fee for papers received and accepted for publication in Acta Poloniae Pharmaceutica Drug Research. The fee is 1500 PLN for Polish authors and 340 € for foreign authors. Publication fees are payable upon article acceptance. Fees are subject to change and charged at the applicable rates effective on your submission date. Articles accepted in principle will not be published without payment fee.

 

Instructions for Authors (PDF)

 

INSTRUCTIONS FOR AUTHORS

Submission of manuscripts

All manuscripts should be submitted exclusively online at https://www.editorialsystem.com/appdr/

Submissions of hardcopy manuscripts or by e-mail will not be accepted.

In addition to the Guidelines, authors are urged to follow these formats when preparing a manuscript. Commonly used file formats (DOC, DOCX, RTF) should be used for preparation of the manuscripts. PDF files are not accepted. The manuscript has to be accompanied by a cover letter, in which the authors briefly explain the significance of their findings and the interest to the readership of Acta Poloniae Pharmaceutica – Drug Research. The manuscript (main text, including tables) should be submitted as one file. All figures should be submitted separately. Only manuscripts of highest scientific quality/novelty, concisely written and complying with these Instructions for Authors can be considered for publication. All contributions are peer-reviewed by independent referees. Submission of a manuscript to Acta Poloniae Pharmaceutica – Drug Research implies that it represents review/original research not previously published and that it is not being considered for publication elsewhere. The corresponding author must declare that the manuscript is submitted on behalf of all authors. Copyright belongs to the publisher upon acceptance of the manuscript.

Scope of the Journal

Acta Poloniae Pharmaceutica – Drug Research

Journal of Polish Pharmaceutical Society is published in 6 issues a year. The following areas of pharmaceutical sciences are covered: Analysis, Biopharmacy, Drug Biochemistry, Drug Synthesis, Natural Drugs, Pharmaceutical Technology, Pharmacology, and General. Acta Poloniae Pharmaceutica – Drug Research publishes Reviews, Original Research Article as well as Short Communications are also accepted.

Preparation of the manuscript

Articles should be written in English, double-spaced. Full name (first, middle initial, last) and address of authors should follow the title written in CAPITAL LETTERS. The abstract should be followed by keywords. We suggest the following structure of paper: l) Introduction, 2) Experimental, 3) Results, 4) Discussion and Conclusion, 5) References. Acta Poloniae Pharmaceutica does not accept files as a supplementary material.

Instructions for citation of references in the journal:

1. In the text, sequential numbers of citations should be in order of appearance (not alphabetically) in parentheses (...) not in brackets […].

2. In the list of references, for papers the correct order is: number of reference with dot, family name and initial(s) of author(s), colon, proper abbreviation(s) for journal (Pubmed, Web of Science, no dot neither coma after one word journal name), number of volume, number of issue (if necessary) in parentheses. first page or number of the paper, year of publication (in parentheses), dot. For books: number of reference with dot, family name and initial(s) of author(s), colon, title of chapter and/or book names and initials of editors (if any), edition number, page(s) of corresponding information (if necessary), publisher name, place and year of publication.

 

EXAMPLES:

  1. Gadzikowska M., Grynkiewicz G.: Acta Pol. Pharm. 59, 149 (2002).
  2. Gilbert A.M., Stack G.P., Nilakantan R., Kodah J., Tran M. et al.: Bioorg. Med. Chem. Lett. 14, 515 (2004).
  3. Roberts S.M.: Molecular Recognition: Chemical and Biochemical Problems, Royal Society of Chemistry, Cambridge 1989.
  4. Salem I.I.: Clarithromycin, in Analytical Profiles of Drug Substances And Excipients. Brittain H.G. Ed., pp. 45-85, Academic Press, San Diego 1996.
  5. Homan R.W., Rosenberg H.C.: The Treatment of Epilepsy, Principles and Practices. p. 932, Lea & Febiger, Philadelphia 1993.
  6. Balderssarini R.J.: in The Pharmacological Basis of Therapeutics, 8th ed., Goodman L., Gilman A., Rall T.W., Nies A.S., Taylor P. Eds., Vol 1, p. 383, Pergamon Press, Maxwell Macmillan Publishing Corporation, New York 1985.
  7. International Conference on Harmonization Guidelines, Validation of analytical procedures, Proceeding of the International Conference on Harmonisation (ICH), Commission of the European Communities, Geneva 1996.
  8. http://www.nhlbi.nih.gov/health/health-topics/topics/ms/ (accessed on 03.10.2017).

 

Chemical nomenclature should follow the rules established by the International Union of Pure and Applied Chemistry, the International Union of Biochemistry and Chemical Abstracts Service. Chemical names of drugs are preferred. If generic name is employed, its chemical name or structural formula should be given at point of first citation. Articles should be written in the Past Tense and Impersonal style. I, we, me, us etc. are to be avoided, except in the Acknowledgment section. Editor reserves the right to make any necessary corrections to a paper prior to publication.

Tables, illustrations

Each table, figure or scheme should be on a separate page together with the relevant legend and any explanatory notes. Tables ideally should not have more than 70, and certainly not more than 140,

characters to the line (counting spaces between columns 4 characters) unless absolutely unavoidable. Good quality line drawings using black ink on plain A4 paper or A4 tracing paper should be submitted with all lettering etc., included. Good black and white photographs are also acceptable. Captions for illustrations should be collected together and presented on a separate

sheet. All tables and illustrations should be specially referred to in the text.

Short Communications

The same general rules apply like for regular articles, except that an abstract is not required, and the number of figures and/or tables should not be more than two in total. The Editors reserve the right to publish (upon agreement of Author(s) as a Short Communication a paper originally submitted as a full-length research paper).

General Information on Article Processing Charges (APC)

Since January 2017 there is a publication fee for papers received and accepted for publication in the Acta Poloniae Pharmaceutica - Drug Research. The fee is 1500 PLN for Polish authors and 340 € for foreign authors. Publication fees are payable upon article acceptance. Fees are subject to change and charged at the applicable rates effective on your submission date.

Articles accepted in principle will not be published without payment fee.

We would like to inform that your paper will be published after receiving publishing fee and the publishing agreement. In order to receive the invoice, please complete the form including data for invoicing, which is available in the payment bookmark in the Editorial System. Failure to complete this form means that you choose not to obtain the invoice.

Please download:

For Polish Authors: https://www.editorialsystem.com/files/appdr/docs/Agreement_PL.pdf

For Foreign Authors: https://www.editorialsystem.com/files/appdr/docs/Agreement_EN.pdf

 

Print, sign (all authors) and send back by a regular mail (hard copy) to:

Mrs. Hanna Plata

Polskie Towarzystwo Farmaceutyczne

ul. Długa 16, 00-238 Warszawa, Poland

Details for charges before publication:

 

For Foreign Authors:

  1. SWIFT Address: BANK MILLENNIUM SA, 02-593 WARSZAWA, POLAND, STANISŁAWA ŻARYNA 2A St.
  2. SWIFT CODE: BIGBPLPWXXX
  3. Beneficiary account Number: PL 30 1160 2202 0000 0000 2777 0200
  4. Bank Name BANK MILLENNIUM SA
  5. Favoring: POLSKIE TOWARZYSTWO FARMACEUTYCZNE (Polish Pharmaceutical Society), DŁUGA 16, 00-238 WARSZAWA, Poland, NIP 526-025-19-54
  6. Purpose of sending money - Publication fee for Acta Pol. Pharm. paper no:…
  7. Amount of money: 340 euro
  8. If you will pay by Western Union the name of recipient is Katarzyna Trembulak at the address as above (Polish Pharmaceutical Society).

 

For Polish Authors:

  1. BANK MILLENNIUM SA, 02-593 WARSZAWA, POLAND, STANISŁAWA ŻARYNA 2A St.
  2. Beneficiary account Number: 29 1160 2202 0000 0000 2770 0281
  3. Favoring: POLSKIE TOWARZYSTWO FARMACEUTYCZNE (Polish Pharmaceutical Society), DŁUGA 16, 00-238 WARSZAWA, Poland, NIP 526-025-19-54
  4. Purpose of sending money - Publication fee for Acta Pol. Pharm. paper no:…
  5. Amount of money: 1500 PLN

 

 

Zobacz również: